# Oklahoma Blood Institute  Texas Blood Institute – FDA Inspection, Apr 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-texas-blood-institute/d68fcfce-8881-43c3-8077-d6b583357a49
Source feed: FDA_Inspections

> FDA inspection 1168570 of Oklahoma Blood Institute  Texas Blood Institute, April 22, 2022. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1168570
- Company Name: Oklahoma Blood Institute  Texas Blood Institute
- Inspection Date: 2022-04-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1027102 - 2017-09-22
- FDA Inspection 858221 - 2013-12-04
- FDA Inspection 728160 - 2011-05-05
- FDA Inspection 604725 - 2009-08-12

Company: https://www.keypedia.com/companies/oklahoma-blood-institute-texas-blood-institute/bbaf5735-cef1-4dce-ad45-4d2c177e274c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d